Erratum to: Rates of BRCA1/2 mutation testing among young survivors of breast cancer (Breast Cancer Res Treat, (2016), 155, (165-173), 10.1007/s10549-015-3658-y)

Kenneth L. Kehl, Chan Shen, Jennifer K. Litton, Banu Arun, Sharon H. Giordano

Research output: Contribution to journalComment/debate

Abstract

In the original publication of the article, the first sentence in the last paragraph of second page was published erroneously as, “We identified BRCA1/2 testing claims using mutation-specific HCPCS procedure codes S1818–S1823, as previously described [8].” The correct sentence should read as, ȁWe identified BRCA1/2 testing claims using mutation-specific HCPCS procedure codes S3818–S3823, as previously described [8].” The authors regret this error.

Original languageEnglish (US)
Number of pages1
JournalBreast Cancer Research and Treatment
Volume159
Issue number1
DOIs
StatePublished - Aug 1 2016

Fingerprint

Healthcare Common Procedure Coding System
Breast Neoplasms
Mutation
Publications
Emotions

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

@article{ed38c75950a64dcf82574d2d6b985191,
title = "Erratum to: Rates of BRCA1/2 mutation testing among young survivors of breast cancer (Breast Cancer Res Treat, (2016), 155, (165-173), 10.1007/s10549-015-3658-y)",
abstract = "In the original publication of the article, the first sentence in the last paragraph of second page was published erroneously as, “We identified BRCA1/2 testing claims using mutation-specific HCPCS procedure codes S1818–S1823, as previously described [8].” The correct sentence should read as, ȁWe identified BRCA1/2 testing claims using mutation-specific HCPCS procedure codes S3818–S3823, as previously described [8].” The authors regret this error.",
author = "Kehl, {Kenneth L.} and Chan Shen and Litton, {Jennifer K.} and Banu Arun and Giordano, {Sharon H.}",
year = "2016",
month = "8",
day = "1",
doi = "10.1007/s10549-016-3922-9",
language = "English (US)",
volume = "159",
journal = "Breast Cancer Research and Treatment",
issn = "0167-6806",
publisher = "Springer New York",
number = "1",

}

Erratum to : Rates of BRCA1/2 mutation testing among young survivors of breast cancer (Breast Cancer Res Treat, (2016), 155, (165-173), 10.1007/s10549-015-3658-y). / Kehl, Kenneth L.; Shen, Chan; Litton, Jennifer K.; Arun, Banu; Giordano, Sharon H.

In: Breast Cancer Research and Treatment, Vol. 159, No. 1, 01.08.2016.

Research output: Contribution to journalComment/debate

TY - JOUR

T1 - Erratum to

T2 - Rates of BRCA1/2 mutation testing among young survivors of breast cancer (Breast Cancer Res Treat, (2016), 155, (165-173), 10.1007/s10549-015-3658-y)

AU - Kehl, Kenneth L.

AU - Shen, Chan

AU - Litton, Jennifer K.

AU - Arun, Banu

AU - Giordano, Sharon H.

PY - 2016/8/1

Y1 - 2016/8/1

N2 - In the original publication of the article, the first sentence in the last paragraph of second page was published erroneously as, “We identified BRCA1/2 testing claims using mutation-specific HCPCS procedure codes S1818–S1823, as previously described [8].” The correct sentence should read as, ȁWe identified BRCA1/2 testing claims using mutation-specific HCPCS procedure codes S3818–S3823, as previously described [8].” The authors regret this error.

AB - In the original publication of the article, the first sentence in the last paragraph of second page was published erroneously as, “We identified BRCA1/2 testing claims using mutation-specific HCPCS procedure codes S1818–S1823, as previously described [8].” The correct sentence should read as, ȁWe identified BRCA1/2 testing claims using mutation-specific HCPCS procedure codes S3818–S3823, as previously described [8].” The authors regret this error.

UR - http://www.scopus.com/inward/record.url?scp=84979985983&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84979985983&partnerID=8YFLogxK

U2 - 10.1007/s10549-016-3922-9

DO - 10.1007/s10549-016-3922-9

M3 - Comment/debate

AN - SCOPUS:84979985983

VL - 159

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

SN - 0167-6806

IS - 1

ER -